Koyfin Home > Directory > Health Care > Inovio Pharma > Capital Expenditures

Inovio Pharma Capital Expenditures Chart (INO)

Inovio Pharma annual/quarterly Capital Expenditures from 2010 to 2020.
  • Inovio Pharma Capital Expenditures for the quarter ending June 06, 2020 was $0m a -275.68% increase of 0m year over year
  • Inovio Pharma Capital Expenditures for the last 12 months ending June 06, 2020 was $0m a -186.48% increase of 1m year over year
  • Inovio Pharma Annual Capital Expenditures for 2019 was $-1m a -111.05% increase of 1m from 2018
  • Inovio Pharma Annual Capital Expenditures for 2018 was $-2m a -393.71% increase of 8m from 2017
  • Inovio Pharma Annual Capital Expenditures for 2017 was $-10m a 73.40% decrease of -8m from 2016
Other Cash Flow Metrics:
  • Inovio Pharma Cash Flow from Operations for the quarter ending December 12, 2018 was $-17m a 27.23% decrease of -5m year over year
  • Inovio Pharma Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-18m a 95.05% decrease of -17m year over year
  • Inovio Pharma Total Revenue for the quarter ending September 09, 2018 was $2m a -339.17% decrease of -7m year over year
View Chart On Koyfin

Quarterly INO Capital Expenditures Data

06/2020$0m
03/2020$0m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$-1m
12/2018$0m
09/2018$0m
06/2018$0m
03/2018$-1m

Annual INO Capital Expenditures Data

2019$-1m
2018$-2m
2017$-10m
2016$-3m
2015$-3m
2014$-1m
2013$0m
2012$0m
2011$0m
2010$0m